For more information please contact:
Head of Healthcare
Michael Margolis, R.Ph
Warren Dunnavant II
Equity Capital Markets
Head of Equity
Senior Vice President
Senior Vice President
Capricor Therapeutics, Inc. (NASDAQ: CAPR) has completed a placement of 3,090,625 shares of its common stock, which includes the full exercise of the over-allotment option, at an offering price of $3.20 per share. Cedars-Sinai Medical Center, a stockholder of Capricor, will purchase 312,500 shares from Capricor directly, in a concurrent registered direct offering. The proceeds to Capricor from the offerings are expected to be approximately $10 million.
ROTH Capital Partners acted as Joint Book-Running Manager in the offering.
About Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Capricor's lead candidate, CAP-1002, is a cardiac cell therapy that is currently being evaluated for the treatment of heart disease associated with Duchenne muscular dystrophy and myocardial infarction (heart attack). Capricor is advancing its proprietary exosome product candidate, CAP-2003, for the treatment of ophthalmic disorders and is exploring other therapeutic areas. Capricor's portfolio also features Cenderitide, a dual natriuretic peptide receptor agonist, which may have application for the outpatient treatment of advanced heart failure and other potential indications. For more information, visit
http://capricor.com. (Source: Company
Press Release | 9/16/16)
About ROTH Capital Partners
ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access. Headquartered in Newport Beach, CA, ROTH is privately-held and employee owned, and maintains offices throughout the U.S. For more information on ROTH, please visit